IGH/CCND1:T(11;14), NHL/MM, HEPARIN BLOOD

image not found

NABL Cap Accredited   
This test detects the t(11;14)(q13;q32) chromosomal translocation involving the IGH and CCND1 genes, commonly seen in mantle cell lymphoma (MCL) and certain cases of multiple myeloma (MM). Identifying this genetic abnormality helps in confirming diagnosis, understanding disease biology, and guiding treatment strategies. The analysis supports clinicians in differentiating specific lymphoma and myeloma subtypes. Metropolis Healthcare performs this test using advanced molecular techniques for precise and reliable detection 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 5,195.00

Sample Type: Sodium Heparin Blood

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What does the IGH/CCND1 test detect?
It identifies the t(11;14) translocation that results in overexpression of the CCND1 (Cyclin D1) gene.

Why is this test important?
It helps diagnose mantle cell lymphoma and certain multiple myeloma cases, and assists in determining prognosis.

Is any preparation needed for the test?
No special preparation is required for a heparin blood sample.

Who should undergo this test?
Patients suspected of having mantle cell lymphoma or specific subtypes of multiple myeloma.

How is the test performed?
Metropolis Healthcare uses sensitive molecular assays such as FISH to detect the IGH/CCND1 rearrangement accurately.

Can this test influence treatment decisions?
Yes, identifying this translocation helps clinicians select appropriate therapeutic approaches.

Are the results reliable?
Yes, results are backed by robust quality standards and validated laboratory methods at Metropolis Healthcare

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab